Sarepta Therapeutics, Inc. (SRPT)

NASDAQ: SRPT · Real-Time Price · USD

15.68

-0.20 (-1.26%)

At close: Jul 24, 2026, 4:00 PM EDT

15.70

+0.02 (0.13%)

After-hours: Jul 24, 2026, 7:58 PM EDT

Sarepta Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,655	2,259	11,782	9,039	11,397	7,846
Market Cap Growth	26.46%	-80.83%	30.35%	-20.69%	45.26%	-42.02%
Enterprise Value	2,049	2,348	11,757	8,741	11,025	6,868
Last Close Price	15.68	21.52	121.59	96.43	129.58	90.05
PE Ratio	24.59	-	51.96	-	-	-
Forward PE	20.01	90.12	15.47	-	-	-
PEG Ratio	-	7.48	-	-	-	-
PS Ratio	0.76	1.03	6.19	7.27	12.21	11.18
PB Ratio	1.10	1.98	7.71	10.52	29.61	8.45
P/TBV Ratio	1.13	1.89	8.59	10.37	29.47	8.01
P/FCF Ratio	14.41	-	-	-	-	-
P/OCF Ratio	9.44	-	-	-	-	-
EV/Sales Ratio	0.94	1.07	6.18	7.03	11.82	9.79
EV/EBITDA Ratio	490.85	-	49.95	-	-	-
EV/EBIT Ratio	-	-	53.91	-	-	-
EV/FCF Ratio	17.84	-	-	-	-	-
Debt / Equity Ratio	0.69	0.90	0.87	1.48	4.16	1.23
Debt / EBITDA Ratio	248.30	-	5.65	-	-	-
Net Debt / Equity Ratio	0.26	0.08	-0.02	-0.35	-0.97	-1.05
Net Debt / EBITDA Ratio	91.85	-0.13	-0.11	1.19	0.75	2.32
Net Debt / FCF Ratio	-1.03	-0.29	0.07	0.52	1.04	2.03
Asset Turnover	0.67	0.60	0.53	0.39	0.30	0.23
Inventory Turnover	0.85	1.01	0.59	0.57	0.72	0.46
Quick Ratio	2.10	1.22	2.67	3.18	3.56	5.01
Current Ratio	4.63	2.32	4.20	3.95	4.13	5.75
Return on Equity (ROE)	4.92%	-53.47%	19.71%	-86.15%	-107.16%	-49.57%
Return on Assets (ROA)	-3.34%	-19.44%	5.44%	-8.63%	-17.42%	-14.99%
Return on Invested Capital (ROIC)	-6.99%	-52.05%	19.06%	-96.00%	-	-
Return on Capital Employed (ROCE)	-1.66%	-25.51%	7.47%	-10.46%	-20.61%	-17.47%
Earnings Yield	3.93%	-	1.92%	-	-	-
FCF Yield	6.94%	-	-	-	-	-
Buyback Yield / Dilution	-10.78%	7.19%	-16.75%	-5.53%	-7.75%	-4.24%
Total Shareholder Return	-10.78%	7.19%	-16.75%	-5.53%	-7.75%	-4.24%

SEC Filings: 10-K · 10-Q